Literature DB >> 30590049

OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis.

Guangyong Sun1, Hua Jin1, Chunpan Zhang1, Hua Meng2, Xinyan Zhao3, Dan Wei2, Xiaojuan Ou4, Qianyi Wang4, Shuxiang Li3, Tianqi Wang1, Xiaojing Sun1, Wen Shi1, Dan Tian1, Kai Liu1, Hufeng Xu1, Yue Tian1, Xinmin Li1, Wei Guo2, Jidong Jia5, Zhongtao Zhang6, Dong Zhang7.   

Abstract

Both innate and adaptive immune cells are involved in the pathogenesis of nonalcoholic steatohepatitis (NASH), but the crosstalk between innate and adaptive immunity is largely unknown. Here we show that compared with WT mice, OX40-/- mice exhibit decreased liver fat accumulation, lobular inflammation, and focal necrosis after feeding with diets that induce NASH. Mechanistically, OX40 deficiency suppresses Th1 and Th17 differentiation, and OX40 deficiency in T cells inhibits monocyte migration, antigen presentation, and M1 polarization. Soluble OX40 stimulation alone upregulates antigen presentation, chemokine receptor expression, and proinflammatory cytokine secretion by liver monocytes. Furthermore, plasma soluble OX40 levels are positively associated with NASH in humans, suggesting clinical relevance of the findings. In conclusion, we show a mechanism for T cell regulation of innate immune cells. OX40 is a key regulator of both intrahepatic innate and adaptive immunity, generates two-way signals, and promotes both proinflammatory monocyte and macrophage and T cell function, resulting in NASH development.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NAFLD; OX40; T cell; inflammation; monocyte

Mesh:

Substances:

Year:  2018        PMID: 30590049     DOI: 10.1016/j.celrep.2018.12.006

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  15 in total

1.  Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASH.

Authors:  Xiaoya Li; Jing Wang; Xue Gong; Meiling Zhang; Shuangshuang Kang; Bing Shu; Zuzhuang Wei; Zhi-Shu Huang; Ding Li
Journal:  Nucleic Acids Res       Date:  2020-09-04       Impact factor: 16.971

Review 2.  Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis.

Authors:  Ki Wung Chung; Ye Eun Cho; Seung-Jin Kim; Seonghwan Hwang
Journal:  Arch Pharm Res       Date:  2022-04-07       Impact factor: 4.946

Review 3.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

4.  PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease.

Authors:  Maria E Moreno-Fernandez; Daniel A Giles; Jarren R Oates; Calvin C Chan; Michelle S M A Damen; Jessica R Doll; Traci E Stankiewicz; Xiaoting Chen; Kashish Chetal; Rebekah Karns; Matthew T Weirauch; Lindsey Romick-Rosendale; Stavra A Xanthakos; Rachel Sheridan; Sara Szabo; Amy S Shah; Michael A Helmrath; Thomas H Inge; Hitesh Deshmukh; Nathan Salomonis; Senad Divanovic
Journal:  Cell Metab       Date:  2021-05-17       Impact factor: 31.373

Review 5.  Adaptive immunity: an emerging player in the progression of NAFLD.

Authors:  Salvatore Sutti; Emanuele Albano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-10-11       Impact factor: 46.802

Review 6.  Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Tatsuo Kanda; Taichiro Goto; Yosuke Hirotsu; Ryota Masuzaki; Mitsuhiko Moriyama; Masao Omata
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

7.  CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis.

Authors:  Guangyong Sun; Xinyan Zhao; Mingyang Li; Chunpan Zhang; Hua Jin; Changying Li; Liwei Liu; Yaning Wang; Wen Shi; Dan Tian; Hufeng Xu; Yue Tian; Yongle Wu; Kai Liu; Zhongtao Zhang; Dong Zhang
Journal:  Nat Commun       Date:  2021-01-28       Impact factor: 14.919

Review 8.  Noncanonical NF-κB Signaling Pathway in Liver Diseases.

Authors:  Qianhui Chen; Xinyu Lu; Xiaoyong Zhang
Journal:  J Clin Transl Hepatol       Date:  2020-12-21

9.  Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma.

Authors:  Ping Tao; Liang Hong; Wenqing Tang; Qun Lu; Yanrong Zhao; Si Zhang; Lijie Ma; Ruyi Xue
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

Review 10.  The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases.

Authors:  Siwen Zhang; Xiaokun Gang; Shuo Yang; Mengzhao Cui; Lin Sun; Zhuo Li; Guixia Wang
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.